Deal Snapshot
ANI Pharmaceuticals Acquires New Drug Applications from Sandoz
Wednesday 07 April 2021

US-based ANI Pharmaceuticals, Inc (NASDAQ: ANIP) has acquired the new drug applications for Oxistat Lotion, Veregen Ointment, and Pandel Cream and the abbreviated new drug application for ApexiCon E Cream from German drugmaker Sandoz Inc, the company said.

Pandel Cream will be transitioned later upon receiving the requisite approvals. Collectively, these products generated net revenues of USD 13.2m in 2020. The acquisition was funded through borrowings under the company's pre-existing revolver credit facility.

Date Published: 07/04/2021